Knowledge attitude and practices about adverse drug reactions among community pharmacists in few areas of bangalore - a cross sectional survey

Abstract

Background: Adverse drug events remain a major cause of morbidity and morbidity. The World Health Organization defines an adverse drug reaction (ADR) as any noxious, unintentional and undesired effect of a drug, which occurs at doses used in humans for prophylaxis, diagnosis, or therapy. Any drug may cause an adverse drug reaction. India is one of the largest drug consuming countries in the world with substantial irrational prescribing and therefore increased likelihood of development of ADRs.

Aim and Objectives: The aim of the study was to assess the knowledge, Attitude and Practices about Adverse drug reaction and educate about ADRs and its complications among community pharmacists.

Methods: It is a Community based, Prospective, Cross-sectional and Observational study with  sample sizes of (N = 326 ) and only community pharmacists are considered into study

Results: This study was based on knowledge, Attitude and practices towards ADRs among community pharmacists with male (77.6%) and females(2.39%) qualification is Dpharm and

B pharm were mainly involved in this study with  experience of   less then 1 year (47.23%) , 1-5 year experience (30.06%) , 6-10 years experience(19.93%) and above 10 years(2.76%).In our study only 24.53% defined ADRs correctly, regarding knowledge about reporting ADRs 47.85% of does not know how and where to report ADRs.

Conclusion: This study concluded that Community pharmacists had positive attitude towards ADRs reporting but their knowledge is needed to be improved. Several approaches like continuing pharmacy education (CPE) and CME training programmes, seminars and conferences should be adopted to create awareness. The pharmacists must be encouraged and constantly motivated towards ADR reporting.

1. Pirmohamed, M., Breckenridge, A., Kitteringham, N. and Park, B. (1998) Adverse drug reactions. Br Med J ;globally-morbidity.


2. Beijer HJ, DeBlaey CJ. Hospitalizations caused by adverse drug reactions (ADRs): A meta-analysis of observational studies. Pharm World Sci. 2002;ADRs-avertable.


3. Sengupta A. Universal Health care in India making it public. Ontario, Canada: IRDC; 2013;india-ADRs.


4. John LJ, Arifulla M, Cheriathu JJ, Sreedharan J. Reporting of adverse drug reactions: An exploratory study among nurses in a teaching hospital, Ajman, United Arab Emirates. Daru 2012; medication-reaction.


5. Major E. The yellow card scheme and the role of pharmacists as reporters. Pharm J. 2002;reporting-ADRs.


6. Shulman JI, Shulman S, Haines AP. The prevention of adverse drug reactions--a potential role for pharmacists in the primary care team? J R Coll Gen Pract. 1981;ADRs-reporting.


7. Bateman, D., Sanders, G. and Rawlins, M. (1992) Attitudes to adverse drug reaction reporting in the Northern Region. Br J Clin Pharmacol ;factors-appropriate.


8. Belton, K., Lawis, S., Payne, S. and Rawlins, M. (1995) (1997) Attitudinal survey of adverse drug reaction reporting by medical practitioners in the United Kingdom. Br J Clin Pharmacol ;certain-appropriate.


9. Eland, I., Belton, K., van Grootheest, A., Meiners, A., Rawlins, M. and Stricker, H. (1999) Attitudinal survey of voluntary reporting of adverse drug reactions. Br J Clin Pharmacol ;affect-form.


10. Williams, D. and Freely, J. (1999) Underreporting of adverse drug reactions: attitudes of Irish doctors. Ir J Med Sci ;physician-form.


11. Backstrom, M., Mjorndal, T., Dahlqvist, R. and Nordkvist-Olsson, T. (2000) Attitudes to reporting adverse drug reactions in northern Sweden. Eur J Clin Pharmacol ;certain-form.


12. Davis, S. and Coulson, R. (1999) Community pharmacist reporting of suspected ADRs: the first year of the yellow card demonstration scheme. Pharm J ;these-ADRs.


13. Van Grootheest, A., Passier, J. and van Puijenbroek, E. (2005) Direct reporting of side effects by the patient: favourable experience in the first year. Ned Tijdschr Geneeskd ,van Grootheest, K., Olsson, S., Couper, M. and de Jong-van den Berg, L. (2004) Pharmacists’ role in reporting adverse drug reactions in an international perspective. Pharmacoepidemiol Drug Saf ;these-ADRs.


14. Morrison-Griffiths, S., Walley, T., Park, B., Breckenridge, A. and Pirmohamed, M. (2003) Reporting of adverse drug reactions by nurses. Lancet ;main-report.


15. Kaliyaperumal K. Guidelines for conducting a knowledge, attitude, and practice (KAP) study. Community Ophthalmol 2004;pharmacovigilance-product.


16. Van Grootheest, A., Mes, K. and de Jong-van den Berg, L. (2002) Attitudes of community pharmacists in the Netherlands towards adverse drug reaction reporting. Int J Pharm Pract ;most-system.


17. Vivek Kunduru,Naveen, Pathakala, VasudhaBakshi, NarenderBoggula,A study of knowledge and awareness of community pharmacist towards ADR reporting.


18. Tahir M.Khan,community pharmacist knowledge and perception about adverse drug reactions and barriers towards their reporting in eastern region,Alasha,Saudi Arabia.


19. Ravinder K.Sah,knowledge,attitude and practice of pharmacovigilance among community pharmacists in delhi,india.


20. Gavaza P, Bui B, Candidate P. Pharmacy students’ attitudes toward reportingserious adverse drug events. Am J Pharm Educ. 201;number-reporting,cross sectional-students,majority-reporting.


21. Elkalmi RM, Hassali MA, Ibrahim MI, Widodo RT, Efan QM, Hadi MA.Pharmacy students’ knowledge and perceptions about pharmacovigilancein Malaysian public universities. Am J Pharm Educ. 2011;cross sectional-reporting.


22. Ahmad A, Khan MU, Moorthy J, Kumar BD, Kumar GS, Patel I. Comparisonof knowledge, attitudes and perceived barriers towards adverse drugreactions reporting between bachelor of pharmacy and doctor of pharmacystudents in southern India. J Pharma Health Serv Res. 2016;number-reporting.


23. Farha RA, Alsous M, Elayeh E, Hattab D. A cross-sectional study onknowledge and perceptions of pharmacovigilance among pharmacystudents of selected tertiary institutions in Jordan. Tropical J PharmRes. 2015;majority-reporting.


24. Isfahani ME, Mousavi S, Rakhshan A, Assarian M, Kuti L, Eslami K.Adverse drug reactions: knowledge, attitude and practice of pharmacystudents. J Pharm Care. 2013;cross sectional-reporting.


25. Rajiah K, Maharajan MK, Nair S. Pharmacy students’ knowledge andperceptions about adverse drug reactions reporting and pharmacovigilance.Saudi Pharm J. 2016;number-reporting.


26. Shakeel S, Iffat W, Anjum F, Bushra R, Ibrahim S, Shafiq S. Emergingneed of pharmacovigilance: perspectives of future pharmacist inPakistan. Int J Pharm Teach & Pract. 2014;cross sectional -reporting.


27. Kothari N, Mirza N, Agrawal N, Choudary M, Pichholiya M, MatuleSM, Goyal BK. An evaluation of knowledge and perception of pharmacystudents toward pharmacovigilance and adverse drug event reporting. Asian J Pharmacol. 2015; community-repoting.


28. Suyagh M, Farah D, Farha RA. Pharmacist’s knowledge, practice and attitudes toward pharmacovigilance and adverse drug reactions reporting process. Saudi Pharmaceutical Journal. 2015;study-metal.


29. Nagaraju K, Satheesh KV, Shankar U, Banu R. Creating Awareness of Adverse Drug Reactions in Community Pharmacists. Indian J Pharm Practice. 2015;knowledge-ketal.


30. Prakasam A, Nidamanuri A, Kumar S. Knowledge, perception and practice of pharmacovigilance among community pharmacists in South India. Pharmacy Practice. 2012;similarly-necessarycommunity-ADRs.


31. Salim M. The Current Perspective of Community Pharmacists towards Pharmacovigilance. J Pharmacovigil. 2015;pharmacist-ADRs.

Parthasarathy G, Karin NH, Milap N. Clinic Pharmacy Book: Essential Concepts and Skills. Hyderabad: Universities Press; 2008;community pharmacist-ADRs.